Our network has expanded. PCRN have joined us and rebranded to Momentum Clinical Research.
- Home
- Clinical Trials
Influenza Prevention Studies Brisbane TA 38
Influenza Prevention Study
Taringa Brisbane
Please note that this study has now closed. However, we encourage you to pre-register your interest for future Influenza prevention studies here.
Description
What to expect
Study details
Ages
12 years or older
Duration
The study lasts up to 7 months, which includes up to 6 scheduled clinic visits and 3 telephone calls
Compensation
Eligible participants will be reimbursed for reasonable expenses associated with research study visits
Eligibility Criteria
You, or your child, may qualify for this study if you:
- Are 12 years or older
- Are considered higher risk due to medical conditions such as COPD, Asthma, Heart Disease, Type 1 Diabetes, Prior Stroke, Chronic Kidney Disease OR
- Have a condition or treatment that affects your immune system, such as cancer, a past transplant, HIV OR
- Currently take immune-suppressing medications. Examples include medications like steroids (e.g., Prednisone), chemotherapy, or biologic treatments (e.g., Rituximab, Humira).
Other criteria apply. A member of our team will check if this study is a good fit for you.
Locations
Description
Influenza, commonly known as the flu, is a highly contagious viral infection. Each year, millions of people worldwide experience symptoms such as fever, cough, sore throat, muscle aches, fatigue, and headaches. While most people recover within a week or two, influenza can cause serious complications, particularly in older adults, young children, and those with underlying health conditions. Beyond the physical impact, the flu can disrupt daily routines, limit work and social life, and place a heavy burden on families and communities during seasonal outbreaks.
Current treatments for influenza include antiviral medications, which may shorten illness duration, and seasonal vaccines, which help reduce the risk of infection. However, the flu virus changes frequently, meaning vaccines and treatments must be updated and may not always provide full protection. Clinical research is exploring new long-acting antiviral medicines and prevention strategies. These studies aim to better understand how to protect people from influenza, reduce complications, and limit the spread of infection.
This study is investigating a potential new prevention treatment to better understand how it works in the body and whether it could provide an additional way to protect people from influenza in the future.
What to expect
As a participant you will be randomly assigned to receive 3 subcutaneous injections (under the skin) of either the investigational prevention treatment or a placebo (an inactive treatment).
You will attend regular clinic visits for health assessments, such as symptom questionnaires, nasal swabs and general health monitoring.
Your safety and well-being will be closely monitored by our professional clinical team.
Why join this clinical research study?
- Gain early access to new potential treatments at no cost
- Contribute to research that could improve flu prevention in the future
- Help researchers learn more about influenza and how to protect people from it
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future Influenza prevention studies here.